Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
Transplantation and Cellular Therapy|April 7, 2024
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated ToxicitiesTakuto Takahashi, Benjamin Watkins, Brandi Bratrude, et al.Transplantation and Cellular Therapy|April 6, 2021
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1M Meaghan Granger, Arlene Naranjo, Rochelle Bagatell, et al.The Lancet. Oncology|October 14, 2019
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trialTheodore W Laetsch, Gary Douglas Myers, André Baruchel, et al.Blood|February 13, 2015
Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantationAntiopi Varelias, Kate H Gartlan, Ellen Kreijveld, et al.Blood|June 15, 2023
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse eventsTakuto Takahashi, Mahmoud Al-Kofahi, Mutaz Jaber, et al.Transplantation and Cellular Therapy|March 29, 2023
Effect of Autograft CD34<sup>+</sup> Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System TumorsTristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2021
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT ConsortiumSteven G DuBois, M Meaghan Granger, Susan Groshen, et al.Transplantation and Cellular Therapy|June 19, 2024
Diagnosis of Post-Hematopoietic Stem Cell Transplantation Bronchiolitis Obliterans Syndrome in Children: Time for a Rethink?Shivanthan Shanthikumar, William A Gower, Kenneth R Cooke, et al.JCI Insight|February 15, 2017
An early-biomarker algorithm predicts lethal graft-versus-host disease and survivalMatthew J Hartwell, Umut Özbek, Ernst Holler, et al.Blood|March 17, 2018
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHDHannah Major-Monfried, Anne S Renteria, Attaphol Pawarode, et al.Pageof 8